Related Experiment Video
Updated: Dec 11, 2025
08:58
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
12.6K
Early Intervention in Ulcerative Colitis: Ready for Prime Time?
Virginia Solitano1, Ferdinando D'Amico1,2, Eirini Zacharopoulou3
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090 Milan, Italy.
Journal of Clinical Medicine
|August 23, 2020
Summary
Early intervention for ulcerative colitis (UC) may improve long-term outcomes, similar to Crohn's disease (CD). This approach aims to prevent disease progression and irreversible bowel damage during a critical "window of opportunity".
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Therapeutics
Background:
- Ulcerative colitis (UC) is increasingly recognized as a progressive condition.
- Current step-up treatment approaches often fail to adequately control disease activity in many UC patients.
- Physician underestimation of the UC burden contributes to suboptimal management.
Purpose of the Study:
- To review the evidence supporting early intervention strategies for ulcerative colitis.
- To explore the concept of a
Main Methods:
- Literature review of randomized controlled trials and real-world studies.
- Analysis of data supporting early intervention in Crohn's disease.
- Synthesis of evidence regarding early intervention in ulcerative colitis.
Main Results:
- Evidence suggests ulcerative colitis (UC) shares progressive characteristics with Crohn's disease (CD).
- Early intervention in CD is supported by data to prevent disease progression and bowel damage.
- A similar
- window of opportunity
Conclusions:
- Early intervention in UC, analogous to CD, holds potential for improved patient outcomes.
- Addressing the
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
338
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
338
01:29Drugs for Treatment of Ulcerative Colitis in IBD
342
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
342
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
537
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
537
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
715
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
715
01:29Inflammatory Bowel Disease IV: Pharmacological Management
336
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
336
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
324
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
324